Fulcrum Therapeutics, Inc. · NASDAQ:FULC

Ezekowitz Alan sold 18,000 Fulcrum Therapeutics, Inc. shares (Form 4)

Traded Jun 26, 2026 · Filed Jun 30, 2026

On Jun 26, 2026, Ezekowitz Alan (Director) sold 18,000 Fulcrum Therapeutics, Inc. shares at US$3.65 for US$65,700, leaving 10,927 shares. Filed Jun 30, 2026 (Form 4).

Sold
18,000 shares
Price
US$3.65
Value
US$65,700
Holding after
10,927 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 26, 2026Common StockSale18,000US$3.6510,927Direct

Source

View original at SEC

Related